Literature DB >> 9222178

Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke.

G Schlaug1, B Siewert, A Benfield, R R Edelman, S Warach.   

Abstract

Diffusion-weighted MRI can rapidly detect acute cerebral ischemic injury as hyperintense signal changes, reflecting a decline in the apparent diffusion coefficient (ADC) of water through brain parenchyma, whereas ADC is elevated in the chronic stage because of increased extracellular water content. To determine the time course of these ADC changes, we analyzed 157 diffusion-weighted MRI studies performed at varying time points from the initial ischemic event from 101 patients. Data were expressed as the relative ADC (rADC), the ratio of lesion to control regions of interest. We observed two phases in the time course of rADC changes in acute human stroke: a significant (p < 0.005) reduction in rADC lasting for at least 96 hours from stroke onset (mean, 58.3% of control; SEM, 1.47) and an increasing trend from reduction to pseudonormalization to elevation of rADC values at later subacute to chronic time points (> or = 7 days). We suggest that the persistent reduction of rADC within the first four days may reflect ongoing or progressive cytotoxic edema to a greater degree than extracellular edema and cell lysis.

Entities:  

Mesh:

Year:  1997        PMID: 9222178     DOI: 10.1212/wnl.49.1.113

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  126 in total

Review 1.  The need for objective assessment of the new imaging techniques and understanding the expanding roles of stroke imaging.

Authors:  W T Yuh; T Ueda; M White; M E Schuster; T Taoka
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

2.  Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Authors:  K Yonemura; Y Hasegawa; K Kimura; K Minematsu; T Yamaguchi
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

3.  Diffusion tensor MR imaging of the brain: effect of diffusion weighting on trace and anisotropy measurements.

Authors:  E R Melhem; R Itoh; L Jones; P B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

4.  Neuro-Behçet's disease: analysis of apparent diffusion coefficients.

Authors:  A Kunimatsu; O Abe; S Aoki; N Hayashi; T Okubo; T Masumoto; H Mori; T Yoshikawa; H Yamada; K Ohtomo
Journal:  Neuroradiology       Date:  2003-07-19       Impact factor: 2.804

Review 5.  Diffusion tensor imaging of the brain: review of clinical applications.

Authors:  P C Sundgren; Q Dong; D Gómez-Hassan; S K Mukherji; P Maly; R Welsh
Journal:  Neuroradiology       Date:  2004-04-21       Impact factor: 2.804

6.  Acute effects of alcohol on the human brain: diffusion tensor imaging study.

Authors:  L M Kong; W B Zheng; G P Lian; H D Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

7.  Diffusion-prepared fast imaging with steady-state free precession (DP-FISP): a rapid diffusion MRI technique at 7 T.

Authors:  Lan Lu; Bernadette Erokwu; Gregory Lee; Vikas Gulani; Mark A Griswold; Katherine M Dell; Chris A Flask
Journal:  Magn Reson Med       Date:  2011-12-02       Impact factor: 4.668

8.  Predictability of motor outcome according to the time of diffusion tensor imaging in patients with cerebral infarct.

Authors:  Yong Hyun Kwon; Yong Jae Jeoung; Jun Lee; Su Min Son; Saeyoon Kim; Chulseung Kim; Sung Ho Jang
Journal:  Neuroradiology       Date:  2011-10-21       Impact factor: 2.804

9.  Fetal MR imaging evidence of prolonged apparent diffusion coefficient decrease in fetal death.

Authors:  T Tarui; O S Khwaja; J A Estroff; J N Robinson; P E Grant
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-29       Impact factor: 3.825

10.  The syndrome of delayed post-hypoxic leukoencephalopathy.

Authors:  David Shprecher; Lahar Mehta
Journal:  NeuroRehabilitation       Date:  2010       Impact factor: 2.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.